Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease

JUAN ANTONIO MORENO GUTIERREZ2026-01-292026-01-29202410.3390/ijms250529612-s2.0-85187680368https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37561CatalysisComputer Science ApplicationsInorganic ChemistryMolecular BiologyOrganic ChemistryPhysical and Theoretical ChemistrySpectroscopySemaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Diseaseresearch article